BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7857378)

  • 1. Identification of individuals at high risk for myocardial infarction.
    Assmann G; Schulte H
    Atherosclerosis; 1994 Oct; 110 Suppl():S11-21. PubMed ID: 7857378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study.
    Assmann G; Schulte H
    Am J Cardiol; 1992 Sep; 70(7):733-7. PubMed ID: 1519522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study.
    Assmann G; Schulte H
    Am J Cardiol; 1992 Dec; 70(19):10H-13H. PubMed ID: 1466311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport.
    Assmann G; Schulte H; von Eckardstein A; Huang Y
    Atherosclerosis; 1996 Jul; 124 Suppl():S11-20. PubMed ID: 8831911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.
    Heinrich J; Balleisen L; Schulte H; Assmann G; van de Loo J
    Arterioscler Thromb; 1994 Jan; 14(1):54-9. PubMed ID: 8274478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
    Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
    Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
    Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New and classical risk factors--the Münster heart study (PROCAM).
    Assmann G; Schulte H; Cullen P
    Eur J Med Res; 1997 Jun; 2(6):237-42. PubMed ID: 9182651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation factor VII and the risk of coronary heart disease in healthy men.
    Junker R; Heinrich J; Schulte H; van de Loo J; Assmann G
    Arterioscler Thromb Vasc Biol; 1997 Aug; 17(8):1539-44. PubMed ID: 9301633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Münster Heart Study (PROCAM): total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers.
    Cullen P; Schulte H; Assmann G
    Circulation; 1997 Oct; 96(7):2128-36. PubMed ID: 9337180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics.
    Yano K; Reed DM; McGee DL
    Am J Epidemiol; 1984 May; 119(5):653-66. PubMed ID: 6720665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women.
    Albert CM; Chae CU; Rexrode KM; Manson JE; Kawachi I
    Circulation; 2005 Feb; 111(4):480-7. PubMed ID: 15687137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prospective Cardiovascular Münster Study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension.
    Assmann G; Schulte H
    Am J Cardiol; 1987 May; 59(14):9G-17G. PubMed ID: 3591673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men.
    Assmann G; Schulte H; von Eckardstein A
    Am J Cardiol; 1996 Jun; 77(14):1179-84. PubMed ID: 8651092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM). Prospective Cardiovascular Münster Study.
    Assmann G; Cullen P; Heinrich J; Schulte H
    Isr J Med Sci; 1996 Jun; 32(6):364-70. PubMed ID: 8682642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden coronary death in women.
    Kannel WB; Wilson PW; D'Agostino RB; Cobb J
    Am Heart J; 1998 Aug; 136(2):205-12. PubMed ID: 9704680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S).
    Pyŏrälä K; Pedersen TR; Kjekshus J; Faergeman O; Olsson AG; Thorgeirsson G
    Diabetes Care; 1997 Apr; 20(4):614-20. PubMed ID: 9096989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emergence of triglycerides as a significant independent risk factor in coronary artery disease.
    Assmann G; Schulte H; Funke H; von Eckardstein A
    Eur Heart J; 1998 Oct; 19 Suppl M():M8-14. PubMed ID: 9821011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking, lipoproteins and coronary heart disease risk. Data from the Münster Heart Study (PROCAM).
    Cullen P; Schulte H; Assmann G
    Eur Heart J; 1998 Nov; 19(11):1632-41. PubMed ID: 9857915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.